Cash flow Align Technology, Inc.

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 02:30:00 05/03/2026 am IST			5-day change	1st Jan Change
182.16 ^USD	-0.26%		-3.13%	+16.66%

27/02	SomnoMed Limited Announces Management Appointments	CI
24/02	Henry Schein beats quarterly profit estimates on stable dental market	RE

3cfc5b604a48c4dfaa60704.1jGX236aHulpZk2N20v-Pse3QT-_2DlGkiLLS6Tjerk.n3rCiQ7Lea8mMyXunXycD7H4FXGSkXst2kOsfpKhGMuHRvntGtJkgVhWdQ

Published financial data: ALIGN TECHNOLOGY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	395.26Cr	373.46Cr	386.23Cr	399.9Cr	403.5Cr
Total Revenues	395.26Cr	373.46Cr	386.23Cr	399.9Cr	403.5Cr
Cost of Goods Sold, Total	101.72Cr	109.8Cr	115.47Cr	119.61Cr	121.84Cr
Gross Profit	293.54Cr	263.67Cr	270.76Cr	280.3Cr	281.66Cr
Selling General & Admin Expenses, Total	170.86Cr	167.45Cr	170.34Cr	176.32Cr	175.58Cr
R&D Expenses	25Cr	31Cr	35Cr	36Cr	37Cr
Other Operating Expenses	-	53T	-	-	-
Other Operating Expenses, Total	195.9Cr	197.98Cr	205.02Cr	212.74Cr	212.57Cr
Operating Income	98Cr	66Cr	66Cr	68Cr	69Cr
Interest And Investment Income	31.03L	53.67L	1.73Cr	2.02Cr	1.6Cr
Net Interest Expenses	31.03L	53.67L	1.73Cr	2.02Cr	1.6Cr
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-1.33Cr	-4.38Cr	-70L	-2.1Cr	1.13Cr
Other Non Operating Income (Expenses)	28.17L	-51.05L	-74.02L	-78.72L	-58.87L
EBT, Excl. Unusual Items	97Cr	61Cr	66Cr	67Cr	71Cr
Restructuring Charges	-	-1.02Cr	-1.4Cr	-3.7Cr	-12Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-49.9L	99.85L	1.81Cr
Asset Writedown	-	-18L	-	-	-2.31Cr
Legal Settlements	4.34Cr	-	-	-3.1Cr	-41.78L
Other Unusual Items	-	-23L	-	-	-
EBT, Incl. Unusual Items	101.24Cr	60Cr	64Cr	61Cr	59Cr
Income Tax Expense	24Cr	24Cr	20Cr	19Cr	17Cr
Earnings From Continuing Operations	77Cr	36Cr	45Cr	42Cr	41Cr
Net Income to Company	77Cr	36Cr	45Cr	42Cr	41Cr
Net Income - (IS)	77Cr	36Cr	45Cr	42Cr	41Cr
Net Income to Common Incl Extra Items	77Cr	36Cr	45Cr	42Cr	41Cr
Net Income to Common Excl. Extra Items	77Cr	36Cr	45Cr	42Cr	41Cr
Per Share Items
Net EPS - Basic	9.78	4.62	5.82	5.63	5.66
Basic EPS - Continuing Operations	9.78	4.62	5.82	5.63	5.66
Basic Weighted Average Shares Outstanding	7.89Cr	7.82Cr	7.64Cr	7.49Cr	7.25Cr
Net EPS - Diluted	9.69	4.61	5.81	5.62	5.65
Diluted EPS - Continuing Operations	9.69	4.61	5.81	5.62	5.65
Diluted Weighted Average Shares Outstanding	7.97Cr	7.84Cr	7.66Cr	7.5Cr	7.26Cr
Normalized Basic EPS	7.67	4.9	5.4	5.57	6.14
Normalized Diluted EPS	7.6	4.89	5.39	5.56	6.13
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	108.51Cr	78Cr	80Cr	82Cr	85Cr
EBITA	99Cr	67Cr	67Cr	69Cr	71Cr
EBIT	98Cr	66Cr	66Cr	68Cr	69Cr
EBITDAR	112.95Cr	84Cr	86Cr	87Cr	90Cr
Effective Tax Rate - (Ratio)	23.75	39.64	30.59	30.81	29.89
Current Domestic Taxes	19Cr	22Cr	16Cr	11Cr	6.69Cr
Current Foreign Taxes	4.27Cr	5.65Cr	5.13Cr	5.67Cr	7.47Cr
Total Current Taxes	23Cr	28Cr	21Cr	17Cr	14Cr
Deferred Domestic Taxes	-3.15Cr	-6.78Cr	-2Cr	49.62L	2.82Cr
Deferred Foreign Taxes	4.34Cr	2.61Cr	19.4L	1.73Cr	51.57L
Total Deferred Taxes	1.2Cr	-4.17Cr	-1.8Cr	2.22Cr	3.33Cr
Normalized Net Income	61Cr	38Cr	41Cr	42Cr	45Cr
Supplemental Operating Expense Items
Advertising Expense	33Cr	-	20Cr	18Cr	19Cr
Selling and Marketing Expenses	33Cr	-	20Cr	18Cr	19Cr
Research And Development Expense From Footnotes	25Cr	31Cr	35Cr	36Cr	37Cr
Net Rental Expense, Total	4.44Cr	6Cr	6.06Cr	4.59Cr	4.75Cr
Stock-Based Comp., COGS (Total)	56.33L	64.38L	74.62L	69.95L	61.77L
Stock-Based Comp., R&D Exp. (Total)	1.8Cr	2.38Cr	3.06Cr	4.27Cr	4.73Cr
Stock-Based Comp., SG&A Exp. (Total)	9.07Cr	10Cr	12Cr	12Cr	13Cr
Total Stock-Based Compensation	11Cr	13Cr	15Cr	17Cr	19Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	109.94Cr	94Cr	94Cr	104.39Cr	109.49Cr
Short Term Investments	7.2Cr	5.75Cr	3.53Cr	-	-
Total Cash And Short Term Investments	117.13Cr	100Cr	97Cr	104.39Cr	109.49Cr
Accounts Receivable, Total	90Cr	86Cr	90Cr	100Cr	110.18Cr
Other Receivables	-	14Cr	14Cr	3.4Cr	5.58Cr
Notes Receivable	-	-	-	-	-
Total Receivables	90Cr	100.02Cr	104.72Cr	102.97Cr	115.76Cr
Inventory	23Cr	34Cr	30Cr	25Cr	23Cr
Prepaid Expenses	7.02Cr	6.91Cr	5.25Cr	8.3Cr	6.25Cr
Other Current Assets, Total	13Cr	1.68Cr	7.73Cr	8.16Cr	7.53Cr
Total Current Assets	249.41Cr	242.44Cr	244.66Cr	249.24Cr	261.66Cr
Gross Property Plant And Equipment	156.23Cr	180.05Cr	195.96Cr	204.62Cr	200.71Cr
Accumulated Depreciation	-36Cr	-45Cr	-55Cr	-66Cr	-77Cr
Net Property Plant And Equipment	120.32Cr	135.07Cr	140.89Cr	138.45Cr	123.98Cr
Long-term Investments	13Cr	4.2Cr	80.22L	-	-
Goodwill	42Cr	41Cr	42Cr	44Cr	49Cr
Other Intangibles, Total	11Cr	9.57Cr	8.21Cr	10Cr	9.39Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	153.38Cr	157.17Cr	159Cr	155.74Cr	151.35Cr
Deferred Charges Long-Term	3.11Cr	2.74Cr	2.51Cr	2.58Cr	2.92Cr
Other Long-Term Assets, Total	1.78Cr	2.84Cr	10Cr	21Cr	25Cr
Total Assets	594.21Cr	594.79Cr	608.39Cr	621.46Cr	623.37Cr
Liabilities
Accounts Payable, Total	16Cr	13Cr	11Cr	11Cr	12Cr
Accrued Expenses, Total	49Cr	32Cr	43Cr	47Cr	43Cr
Current Portion of Leases	2.27Cr	2.66Cr	2.97Cr	3.11Cr	3.19Cr
Current Income Taxes Payable	3.38Cr	7.43Cr	3.81Cr	4.88Cr	4.4Cr
Unearned Revenue Current, Total	115.29Cr	134.36Cr	142.77Cr	133.11Cr	126.18Cr
Other Current Liabilities	6.27Cr	3.78Cr	2.36Cr	4.47Cr	3.49Cr
Total Current Liabilities	192.41Cr	192.59Cr	206.66Cr	203.8Cr	192Cr
Long-Term Leases	10Cr	10Cr	9.7Cr	8.82Cr	8.25Cr
Unearned Revenue Non Current	14Cr	16Cr	14Cr	10Cr	8.55Cr
Other Non Current Liabilities	16Cr	16Cr	15Cr	13Cr	9.65Cr
Total Liabilities	231.94Cr	234.66Cr	245.34Cr	236.26Cr	218.45Cr
Common Stock, Total	8T	8T	7T	7T	7T
Additional Paid In Capital	100Cr	104.49Cr	116.21Cr	136.22Cr	150.96Cr
Retained Earnings	261.94Cr	256.67Cr	244.72Cr	248.38Cr	246.42Cr
Comprehensive Income and Other	43.26L	-1.03Cr	2.12Cr	59.78L	7.54Cr
Total Common Equity	362.27Cr	360.14Cr	363.05Cr	385.2Cr	404.91Cr
Total Equity	362.27Cr	360.14Cr	363.05Cr	385.2Cr	404.91Cr
Total Liabilities And Equity	594.21Cr	594.79Cr	608.39Cr	621.46Cr	623.37Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.88Cr	7.66Cr	7.51Cr	7.36Cr	7.13Cr
ECS Total Common Shares Outstanding	7.87Cr	7.73Cr	7.51Cr	7.38Cr	7.14Cr
Book Value / Share	46.03	46.61	48.36	52.16	56.74
Tangible Book Value	309.45Cr	309.81Cr	312.88Cr	330.59Cr	346.34Cr
Tangible Book Value Per Share	39.31	40.1	41.68	44.77	48.53
Total Debt	13Cr	13Cr	13Cr	12Cr	11Cr
Net Debt	-117.13Cr	-91Cr	-85Cr	-92Cr	-98Cr
Debt Equivalent Oper. Leases	36Cr	48Cr	49Cr	37Cr	38Cr
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	12Cr	17Cr	15Cr	12Cr	11Cr
Inventories - Work In Process, Total	5.17Cr	9.66Cr	9.13Cr	7.37Cr	6.57Cr
Inventories - Finished Goods, Total	5.53Cr	6.94Cr	6.02Cr	5.62Cr	5.34Cr
Land - (BS)	5.89Cr	5.89Cr	6.39Cr	6.39Cr	5.79Cr
Buildings, Total	31Cr	47Cr	52Cr	53Cr	52Cr
Machinery, Total	52Cr	69Cr	83Cr	100.76Cr	100.03Cr
Full Time Employees	22.54T	23.16T	21.61T	20.94T	-
Accumulated Allowance for Doubtful Accounts (Supple)	92.45L	1.03Cr	1.49Cr	1.91Cr	3.42Cr
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	77Cr	36Cr	45Cr	42Cr	41Cr
Depreciation & Amortization - CF	9.21Cr	11Cr	13Cr	13Cr	14Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.66Cr	1.6Cr	1.64Cr	1.89Cr	1.88Cr
Depreciation & Amortization, Total	11Cr	13Cr	14Cr	15Cr	16Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	2.31Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	49.9L	-58.85L	-1.81Cr
Asset Writedown & Restructuring Costs	-	-	-	-	7.7Cr
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	11Cr	13Cr	15Cr	17Cr	19Cr
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	28.14L	-	-	-	-
Other Operating Activities, Total	2.04Cr	3.23Cr	4.72Cr	7.64Cr	11Cr
Change In Accounts Receivable	-26Cr	2.15Cr	-10Cr	-15Cr	-14Cr
Change In Inventories	-11Cr	-13Cr	3.02Cr	2.51Cr	8L
Change In Accounts Payable	1.97Cr	-3.65Cr	-77.03L	-8L	53.3L
Change in Unearned Revenues	46Cr	24Cr	8.67Cr	-8.01Cr	-11Cr
Change In Income Taxes	1.24Cr	63.27L	-77.72L	-2.03Cr	-2.83Cr
Change in Other Net Operating Assets	3.39Cr	-19Cr	-46.86L	16Cr	-8.22Cr
Cash from Operations	117.25Cr	57Cr	79Cr	74Cr	59Cr
Capital Expenditure	-40Cr	-29Cr	-18Cr	-12Cr	-10Cr
Cash Acquisitions	-80.02L	-1.23Cr	-	-7.71Cr	-
Investment in Marketable and Equity Securities, Total	-20Cr	9.31Cr	-1.85Cr	-6.25Cr	-1Cr
Other Investing Activities, Total	4.3Cr	-22.11L	3L	2L	-
Cash from Investing	-56Cr	-21Cr	-20Cr	-25Cr	-11Cr
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	2.56Cr	2.61Cr	2.66Cr	2.53Cr	2.17Cr
Repurchase of Common Stock	-48Cr	-49Cr	-61Cr	-38Cr	-49Cr
Other Financing Activities, Total	-	-4Cr	-1Cr	-	-
Cash from Financing	-46Cr	-50Cr	-60Cr	-36Cr	-46Cr
Foreign Exchange Rate Adjustments	-1.21Cr	-1.15Cr	46.71L	-2.12Cr	3.5Cr
Net Change in Cash	14Cr	-16Cr	-38.36L	11Cr	5.12Cr
Supplemental Items
Cash Income Tax Paid (Refund)	20Cr	23Cr	29Cr	18Cr	13Cr
Levered Free Cash Flow	60Cr	27Cr	62Cr	62Cr	48Cr
Unlevered Free Cash Flow	60Cr	27Cr	62Cr	62Cr	48Cr
Change In Net Working Capital	-16Cr	10Cr	-8.86Cr	46.74L	19Cr
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.33	6.91	6.83	6.87	6.94
Return on Total Capital	17.27	10.98	10.98	10.93	10.62
Return On Equity %	22.52	10.01	12.31	11.26	10.39
Return on Common Equity	22.52	10.01	12.31	11.26	10.39
Margin Analysis
Gross Profit Margin %	74.26	70.6	70.1	70.09	69.81
SG&A Margin	43.23	44.84	44.1	44.09	43.51
EBITDA Margin %	27.45	20.96	20.71	20.52	21.1
EBITA Margin %	25.12	18.02	17.44	17.37	17.59
EBIT Margin %	24.7	17.59	17.02	16.89	17.12
Income From Continuing Operations Margin %	19.53	9.68	11.52	10.54	10.17
Net Income Margin %	19.53	9.68	11.52	10.54	10.17
Net Avail. For Common Margin %	19.53	9.68	11.52	10.54	10.17
Normalized Net Income Margin	15.32	10.26	10.68	10.42	11.03
Levered Free Cash Flow Margin	15.07	7.33	16	15.52	11.99
Unlevered Free Cash Flow Margin	15.07	7.33	16	15.52	11.99
Asset Turnover
Asset Turnover	0.73	0.63	0.64	0.65	0.65
Fixed Assets Turnover	3.91	2.92	2.8	2.86	3.08
Receivables Turnover (Average Receivables)	5.08	4.25	4.38	4.21	3.85
Inventory Turnover (Average Inventory)	5.51	3.86	3.63	4.34	5.07
Short Term Liquidity
Current Ratio	1.3	1.26	1.18	1.22	1.36
Quick Ratio	1.08	1.04	0.98	1.02	1.17
Operating Cash Flow to Current Liabilities	0.61	0.3	0.38	0.36	0.31
Days Sales Outstanding (Average Receivables)	71.79	85.85	83.31	86.91	94.87
Days Outstanding Inventory (Average Inventory)	66.29	94.57	100.47	84.33	71.99
Average Days Payable Outstanding	50.39	44.13	39.52	35.19	35.28
Cash Conversion Cycle (Average Days)	87.68	136.3	144.25	136.05	131.58
Long Term Solvency
Total Debt/Equity	3.46	3.52	3.49	3.1	2.83
Total Debt / Total Capital	3.34	3.4	3.37	3	2.75
LT Debt/Equity	2.83	2.79	2.67	2.29	2.04
Long-Term Debt / Total Capital	2.74	2.69	2.58	2.22	1.98
Total Liabilities / Total Assets	39.03	39.45	40.33	38.02	35.04
Total Debt / EBITDA	0.11	0.15	0.15	0.14	0.13
Net Debt / EBITDA	-1.04	-1.09	-0.99	-1.07	-1.09
Total Debt / (EBITDA - Capex)	0.17	0.23	0.19	0.16	0.14
Net Debt / (EBITDA - Capex)	-1.61	-1.66	-1.25	-1.23	-1.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	59.9	-5.51	3.42	3.54	0.9
Gross Profit, 1 Yr. Growth %	66.48	-10.18	2.8	3.52	0.62
EBITDA, 1 Yr. Growth %	125.74	-27.87	2.55	2.61	4.23
EBITA, 1 Yr. Growth %	147.9	-32.24	0.55	3.07	2.76
EBIT, 1 Yr. Growth %	152.19	-32.72	0.51	2.77	2.85
Earnings From Cont. Operations, 1 Yr. Growth %	-56.53	-53.17	23.09	-5.32	-2.61
Net Income, 1 Yr. Growth %	-56.53	-53.17	23.09	-5.32	-2.61
Normalized Net Income, 1 Yr. Growth %	149.01	-36.7	8.14	1.01	7.43
Diluted EPS Before Extra, 1 Yr. Growth %	-56.76	-52.43	26.03	-3.27	0.53
Accounts Receivable, 1 Yr. Growth %	36.41	-4.18	5.09	10.21	10.65
Inventory, 1 Yr. Growth %	65.35	47.14	-12.35	-14.35	-10.99
Net Property, Plant and Equip., 1 Yr. Growth %	47.22	12.26	4.3	-1.73	-10.45
Total Assets, 1 Yr. Growth %	23.03	0.1	2.29	2.15	0.31
Tangible Book Value, 1 Yr. Growth %	16.38	0.12	0.99	5.66	4.76
Common Equity, 1 Yr. Growth %	12.02	-0.59	0.81	6.1	5.12
Cash From Operations, 1 Yr. Growth %	77.07	-51.5	38.16	-6.05	-19.64
Capital Expenditures, 1 Yr. Growth %	158.91	-27.22	-39.12	-34.96	-11.36
Levered Free Cash Flow, 1 Yr. Growth %	18.24	-54.05	127.32	0.42	-21.78
Unlevered Free Cash Flow, 1 Yr. Growth %	18.24	-54.05	127.32	0.42	-21.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.15	22.92	-1.15	3.48	2.21
Gross Profit, 2 Yr. CAGR %	29.74	22.28	-3.96	3.16	2.01
EBITDA, 2 Yr. CAGR %	35.22	27.6	-14.15	2.58	3.22
EBITA, 2 Yr. CAGR %	38.14	29.61	-17.63	1.81	2.69
EBIT, 2 Yr. CAGR %	37.76	30.26	-17.95	1.63	2.58
Earnings From Cont. Operations, 2 Yr. CAGR %	32.05	-54.88	-24.07	7.95	-3.98
Net Income, 2 Yr. CAGR %	32.05	-54.88	-24.07	7.95	-3.98
Normalized Net Income, 2 Yr. CAGR %	37.66	25.54	-17.46	4.52	3.93
Diluted EPS Before Extra, 2 Yr. CAGR %	32.37	-54.64	-22.57	10.41	-1.39
Accounts Receivable, 2 Yr. CAGR %	27.69	14.33	0.35	7.62	10.43
Inventory, 2 Yr. CAGR %	43.34	55.98	13.56	-13.36	-12.69
Net Property, Plant and Equip., 2 Yr. CAGR %	32.25	28.56	8.21	1.24	-6.19
Total Assets, 2 Yr. CAGR %	54.15	10.97	1.19	2.22	1.22
Tangible Book Value, 2 Yr. CAGR %	56.07	7.94	0.55	3.3	5.21
Common Equity, 2 Yr. CAGR %	64.05	5.53	0.11	3.42	5.61
Cash From Operations, 2 Yr. CAGR %	25.26	-7.32	-18.14	13.93	-13.11
Capital Expenditures, 2 Yr. CAGR %	63.68	37.27	-33.44	-37.07	-24.08
Levered Free Cash Flow, 2 Yr. CAGR %	21.35	-26.29	1.87	51.08	-11.51
Unlevered Free Cash Flow, 2 Yr. CAGR %	21.35	-26.29	1.87	51.08	-11.51
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	26.2	15.77	16.04	0.39	2.61
Gross Profit, 3 Yr. CAGR %	26.56	14.77	15.37	-1.53	2.26
EBITDA, 3 Yr. CAGR %	27.68	9.66	18.49	-8.89	2.97
EBITA, 3 Yr. CAGR %	28.08	8.95	18.93	-11.24	1.94
EBIT, 3 Yr. CAGR %	27.91	8.49	19.3	-11.55	1.84
Earnings From Cont. Operations, 3 Yr. CAGR %	24.48	-6.53	-36.95	-18.28	4.31
Net Income, 3 Yr. CAGR %	24.48	-6.53	-36.95	-18.28	4.31
Normalized Net Income, 3 Yr. CAGR %	28.38	6.25	19.27	-11.71	5.28
Diluted EPS Before Extra, 3 Yr. CAGR %	25.35	-5.89	-36.24	-16.61	7.02
Accounts Receivable, 3 Yr. CAGR %	26.9	16.03	11.16	3.53	8.62
Inventory, 3 Yr. CAGR %	60.54	44.6	28.71	3.37	-12.58
Net Property, Plant and Equip., 3 Yr. CAGR %	32.15	25.22	19.9	4.79	-2.82
Total Assets, 3 Yr. CAGR %	42.52	33.49	8	1.51	1.58
Tangible Book Value, 3 Yr. CAGR %	38.26	34.6	5.57	2.23	3.79
Common Equity, 3 Yr. CAGR %	42.46	38.82	3.93	2.07	3.98
Cash From Operations, 3 Yr. CAGR %	28.34	-8.7	5.87	-14.29	1.42
Capital Expenditures, 3 Yr. CAGR %	21.56	24.93	4.68	-33.95	-29.46
Levered Free Cash Flow, 3 Yr. CAGR %	32.6	-12.21	7.06	1.38	21.16
Unlevered Free Cash Flow, 3 Yr. CAGR %	32.6	-12.21	7.06	1.38	21.16
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	29.63	20.44	14.45	10.69	10.3
Gross Profit, 5 Yr. CAGR %	29.2	18.74	13.34	9.96	9.82
EBITDA, 5 Yr. CAGR %	31.48	14.51	8.94	6.7	12.11
EBITA, 5 Yr. CAGR %	31.54	13.34	7.35	5.94	12.12
EBIT, 5 Yr. CAGR %	31.44	13.19	7.1	5.6	12.28
Earnings From Cont. Operations, 5 Yr. CAGR %	32.41	9.34	2.15	-0.99	-25.4
Net Income, 5 Yr. CAGR %	32.41	9.34	2.15	-0.99	-25.4
Normalized Net Income, 5 Yr. CAGR %	32.1	11.15	7.59	5.46	12.85
Diluted EPS Before Extra, 5 Yr. CAGR %	32.98	10.25	3.38	0.32	-24.09
Accounts Receivable, 5 Yr. CAGR %	29.39	21.54	15.53	12.59	10.87
Inventory, 5 Yr. CAGR %	53.37	60.62	39.78	17.81	10.21
Net Property, Plant and Equip., 5 Yr. CAGR %	47.02	31.1	22	15.01	8.69
Total Assets, 5 Yr. CAGR %	33.6	27.23	24.27	19.97	5.24
Tangible Book Value, 5 Yr. CAGR %	27.64	23.8	21.72	21.08	5.43
Common Equity, 5 Yr. CAGR %	29.48	25.55	23.71	23.4	4.6
Cash From Operations, 5 Yr. CAGR %	36.48	5.34	7.21	-0.24	-2.18
Capital Expenditures, 5 Yr. CAGR %	41.55	8.33	-4.46	-5.04	-7.94
Levered Free Cash Flow, 5 Yr. CAGR %	33.4	12.82	19.33	8.94	-0.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.4	12.82	19.33	8.94	-0.81